Literature DB >> 10692396

Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.

W Ishida1, T Hamamoto, K Kusanagi, K Yagi, M Kawabata, K Takehara, T K Sampath, M Kato, K Miyazono.   

Abstract

Smad6 is an inhibitory Smad that is induced by bone morphogenetic proteins (BMPs) and interferes with BMP signaling. We have isolated the mouse Smad6 promoter and identified the regions responsible for transcriptional activation by BMPs. The proximal BMP-responsive element (PBE) in the Smad6 promoter is important for the transcriptional activation by BMPs and contains a 28-base pair GC-rich sequence including four overlapping copies of the GCCGnCGC-like motif, which is a binding site for Drosophila Mad and Medea. We generated a luciferase reporter construct (3GC2-Lux) containing three repeats of the GC-rich sequence derived from the PBE. BMPs and BMP receptors induced transcriptional activation of 3GC2-Lux in various cell types, and this activation was enhanced by cotransfection of BMP-responsive Smads, i.e. Smad1 or Smad5. Moreover, direct DNA binding of BMP-responsive Smads and common-partner Smad4 to the GC-rich sequence of PBE was observed. These results indicate that the expression of Smad6 is regulated by the effects of BMP-activated Smad1/5 on the Smad6 promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692396     DOI: 10.1074/jbc.275.9.6075

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

Review 1.  New insights into the pathogenesis and treatment of primary pulmonary hypertension.

Authors:  N Rudarakanchana; R C Trembath; N W Morrell
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

2.  Smad proteins regulate transcriptional induction of the SM22alpha gene by TGF-beta.

Authors:  Shiyou Chen; Magdalena Kulik; Robert J Lechleider
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

3.  Negative feedback in the bone morphogenetic protein 4 (BMP4) synexpression group governs its dynamic signaling range and canalizes development.

Authors:  Malte Paulsen; Stefan Legewie; Roland Eils; Emil Karaulanov; Christof Niehrs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-01       Impact factor: 11.205

4.  Transcriptional regulation of BMP4 synexpression in transgenic Xenopus.

Authors:  Emil Karaulanov; Walter Knöchel; Christof Niehrs
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

5.  Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways.

Authors:  Kathleen E Tumelty; Nathan Higginson-Scott; Xueping Fan; Piyush Bajaj; Kelly M Knowlton; Michael Shamashkin; Anthony J Coyle; Weining Lu; Stephen P Berasi
Journal:  J Biol Chem       Date:  2018-01-09       Impact factor: 5.157

Review 6.  Bone morphogenetic proteins and their antagonists.

Authors:  Elisabetta Gazzerro; Ernesto Canalis
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

7.  Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.

Authors:  M Furuhashi; K Yagi; H Yamamoto; Y Furukawa; S Shimada; Y Nakamura; A Kikuchi; K Miyazono; M Kato
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice.

Authors:  Xue-Bin Wu; Yanan Li; Adina Schneider; Wanqin Yu; Gopalan Rajendren; Jameel Iqbal; Matsuo Yamamoto; Mohammad Alam; Lisa J Brunet; Harry C Blair; Mone Zaidi; Etsuko Abe
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  SMAD 8 binding to mice Msx1 basal promoter is required for transcriptional activation.

Authors:  Renata Binato; Cristina E Alvarez Martinez; Luciana Pizzatti; Benoit Robert; Eliana Abdelhay
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

10.  Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension.

Authors:  Ayako Nishihara; Tetsuro Watabe; Takeshi Imamura; Kohei Miyazono
Journal:  Mol Biol Cell       Date:  2002-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.